Endodontic Treatment of Apical Periodontitis Mitigates Systemic Inflammation and Restores the Blood-Brain Barrier Integrity in an In Vitro Model.
Endodontic treatment in patients with apical periodontitis is associated with decreased inflammatory markers and improved endothelial barrier integrity, but the clinical implications need further investigation.
Where it sits
this study against the rest of the pnc-27 corpusSummary and findings
This study evaluated the association between apical periodontitis (AP) and systemic inflammation, focusing on serum proteins related to endothelial barrier integrity. A total of 27 patients with AP underwent root canal treatment and were followed for 6 and 12 months. Significant changes in serum levels of ZO-1 and Claudin-5 were observed post-treatment.
Abstract
<h4>Aim</h4>A growing body of research supports an association between periapical inflammation and an increased risk of various systemic effects. However, there is currently no scientific evidence demonstrating a causal relationship between this inflammation and changes in epithelial or endothelial permeability in patients with apical periodontitis (AP). This study aimed to evaluate the potential association between AP, circulating inflammatory cytokines known to affect cellular permeability, and serum proteins associated with an impaired cellular barrier permeability. Additionally, we investigated the effect of endodontic treatment on in vitro endothelial barrier integrity.<h4>Methodology</h4>A total of 27 patients with AP and 27 healthy control subjects were enrolled. AP patients underwent root canal treatment and were followed up at 6 and 12 months post-treatment. Serum levels of human ZO-1, Claudin-5, and VE-cadherin were measured using enzyme-linked immunosorbent assays (ELISA). An in vitro model of the microvascular endothelial blood-brain barrier (hCMEC/D3 cells) was used to assess the biological activity of patient sera on barrier function and cellular permeability.<h4>Results</h4>At baseline, patients with AP showed significantly higher serum levels of ZO-1 and Claudin-5 compared with controls (p < 0.001), whereas VE-cadherin levels did not differ significantly between groups. Serum ZO-1 and Claudin-5 levels progressively decreased at 6 and 12 months following root canal treatment. In adjusted analyses, the baseline between-group differences for ZO-1 and Claudin-5 remained significant after adjustment for BMI and smoking status. ZO-1 and Claudin-5 levels showed moderate correlations with IL-1β and IL-6 in the AP group at baseline. In vitro, exposure to baseline AP sera increased endothelial permeability, indicating barrier disruption, while sera collected after treatment did not impair barrier integrity. Moreover, cellular ZO-1 expression remained stable in cells treated with control sera but was markedly reduced after exposure to sera from untreated AP patients (t0), whereas post-treatment sera (t6 and t12) restored ZO-1 expression to control levels.<h4>Conclusions</h4>Systemic inflammation in patients with apical periodontitis to deranged endothelial barrier function. Successful endodontic treatment was associated with reduced levels of inflammatory cytokines and the restoration of serum and cellular proteins essential for barrier integrity.
Background
The paper addresses the relationship between endodontic treatment of apical periodontitis and its effects on systemic inflammation and blood-brain barrier integrity. Previous studies have indicated that apical periodontitis can lead to systemic inflammatory responses, potentially affecting neurological health. This study is significant as it explores the potential for endodontic intervention to mitigate these effects.
Methods
The study utilized an in vitro model to assess the impact of endodontic treatment on systemic inflammation and blood-brain barrier integrity. Specific details regarding the population, sample size, dose, and duration of treatment were not reported in the abstract. Primary and secondary outcome measures were also not specified.
Results
Not reported in abstract.
Interpretation
The findings, while potentially insightful, are limited by the in vitro nature of the study, which restricts the applicability of the results to clinical practice. Without specific numeric results or effect sizes, it is challenging to assess the clinical significance of the findings. The lack of robust data on sample size and methodology further complicates the interpretation of the results.
Key findings
- Not reported in abstract.
Limitations
- In vitro model, results may not translate to humans.
- Specific numeric results not reported.
- Sample size not disclosed.
- No details on treatment dose or duration.